|
About the Limits of Nitrosamines category
|
|
0
|
617
|
April 14, 2021
|
|
Nitrosamine testing results
|
|
10
|
555
|
April 18, 2024
|
|
N-nitrososarcosine limit
|
|
2
|
184
|
April 11, 2024
|
|
Whether N-Nitroso Memantine is possible?
|
|
16
|
567
|
April 10, 2024
|
|
EMA Q&A Appendix 1 update posted on Feb. 26, 2024
|
|
11
|
1339
|
April 9, 2024
|
|
Acrostic - facilitating, supporting and documenting read-across!
|
|
4
|
389
|
April 8, 2024
|
|
N-Nitroso Edoxaban Desmethyl Impurity CPCA Score
|
|
6
|
469
|
April 8, 2024
|
|
Overlapping gene/mutation patterns between changes induced in p53 and RAS oncogenes by some nitrosamines with those induced within photocarcinogenesis: a good start to unravel the puzzle?
|
|
2
|
91
|
April 5, 2024
|
|
Request for risk assessment and confirmatory testing for nortriptyline containing products
|
|
4
|
358
|
April 3, 2024
|
|
AI Limit for Nitroso Nebivolol
|
|
11
|
1835
|
April 3, 2024
|
|
🖩 CPCA Calculation Tool (excel-based) -Updated
|
|
82
|
7588
|
April 1, 2024
|
|
🇨🇦 Health Canada updated the guidance and Appendix 1(March 15, 2024)
|
|
10
|
1295
|
March 27, 2024
|
|
AI difference between FDA and EMA, HC and TGA
|
|
0
|
490
|
March 22, 2024
|
|
IVACAFTOR (N-Nitroso Ivacaftor)
|
|
0
|
199
|
March 22, 2024
|
|
Calculating Nitrosamine Limits (MasterClass)
|
|
4
|
1592
|
March 19, 2024
|
|
N-nitroso cyclamate
|
|
9
|
332
|
March 15, 2024
|
|
NDMA evaluation in battery of in vivo Genotoxicity assays once again leading to AI much greater than 96 ng/day
|
|
0
|
163
|
March 13, 2024
|
|
Open-Access Software for Chemical Read-Across
|
|
0
|
184
|
March 12, 2024
|
|
🇺🇸 FDA NDSRI Limits update -Mar 2024
|
|
4
|
503
|
March 12, 2024
|
|
MEGLUMINE (Methylglucamine)
|
|
15
|
1720
|
March 12, 2024
|
|
LOQ for small nitrosamines
|
|
1
|
169
|
March 11, 2024
|
|
AI limit for N-Nitroso Losartan
|
|
4
|
265
|
March 9, 2024
|
|
Define MDD to calculate limit
|
|
39
|
10628
|
March 6, 2024
|
|
Ribociclib Succinate NDSRIs limit clarification related
|
|
6
|
455
|
March 5, 2024
|
|
🇺🇸 FDA - Updated information on recommended AI for NDSRIs (23/Feb/2024) - Tables 2 & 3
|
|
14
|
1234
|
February 27, 2024
|
|
AI value for Nitroso Folic acid
|
|
4
|
1353
|
February 26, 2024
|
|
AI for en Indole struktur (N-Nitroso melatonin)
|
|
8
|
1074
|
February 20, 2024
|
|
Risk characterization of N-nitrosodimethylamine in pharmaceuticals -Pub
|
|
6
|
530
|
February 16, 2024
|
|
Developing and validating read-across workflows that enable decision making for toxicity and potency: Case studies with N-nitrosamines -Pub
|
|
4
|
330
|
February 14, 2024
|
|
Nitrosamines Severity (impact) - a quantitative model proposal?
|
|
3
|
718
|
February 12, 2024
|